News & Events

Apex Tibial Nailing System: Initial surgeon feedback is positive for all fracture types.

Led by OrthoXel’s Chief Medical Officer Professor James Harty, who is also a Consultant Orthopaedic Surgeon at Cork University Hospital, the Apex Tibial Nailing System clinical study commenced in March 2018.   Cork University Hospital is the Level 1 Trauma Centre in Ireland’s second largest city and serves a huge part of the country covering a population of almost half a million.

So far, 30 patients have been implanted with the Apex Tibial Nailing System, covering a wide variety of cases including diverse demographics and a range of tibial fracture types including comminuted fractures and open injuries (Gustilo-Anderson Grade II to IIIB).

The recently published white paper, “Early Healing in High-Risk Fractures Following Apex Micromotion Fixation,” only focused on four of the high-risk cases from the ongoing study.  All of the patients in the study have been treated with the Apex Tibial Nailing System in micromotion locking mode. This enables exceptional torsional stability of the bone while allowing up to 1mm of controlled axial micromotion.  This range of movement is designed to be the optimal for stimulating bone callus formation at the fracture site.

Watch this space for further clinical study updates.